What did @dromaraurakzai actually say?
The creator ran through nine hair loss interventions in quick succession: DHT blockers, minoxidil, PRP, red light therapy, omega oils, microneedling, stem cells, ketoconazole shampoo, and tretinoin combined with minoxidil. Each claim followed a clean if-then structure. For example, they said minoxidil will "regrow your hair stronger and thicker" because it "increases blood flow to the hair follicles and keeps them in the growth phase for longer." They also said red light therapy "wakes up the mitochondria" and that tretinoin "improves absorption of minoxidil and makes it work better." The framing is confident and mechanistic throughout, which sounds authoritative but glosses over meaningful differences in evidence quality between these treatments.
Does the science back this up?
Mostly yes on the established treatments, with some important caveats. The claims about DHT blockers, minoxidil, ketoconazole, and the tretinoin-minoxidil combination are reasonably grounded in clinical literature. The claims about stem cells and red light therapy are not in the same evidence class and should not be presented alongside finasteride as though they are equivalent options.
Finasteride's mechanism as a 5-alpha reductase inhibitor is well established. Rossi et al. (2020, Dermatology and Therapy) confirmed long-term arrest of androgenetic alopecia in a majority of male patients. Minoxidil's effect on the anagen phase is real, though calling regrowth "stronger and thicker" overstates what most patients experience. The tretinoin-minoxidil combination has actual trial support: Bazzano et al. (1986, Archives of Dermatology) showed enhanced minoxidil penetration with tretinoin co-application, and more recent work by Ingprasert et al. (2019, Journal of Dermatological Treatment) replicated the benefit. Ketoconazole's mild anti-androgenic and anti-inflammatory properties are documented in Piérard-Franchimont et al. (1998, Dermatology).
PRP has a messier evidence base. A 2019 meta-analysis by Gupta and Versteeg (Journal of Cutaneous Medicine and Surgery) found statistically significant hair density improvements but noted high heterogeneity across protocols. Microneedling, similarly, has supportive small trials but no standardized depth or frequency recommendation. Red light therapy and stem cell therapy for hair loss remain largely experimental, with limited high-quality RCT data in humans.
What did they get wrong (or right)?
The creator deserves credit for correctly separating mechanisms rather than just listing products. Explaining that ketoconazole has a "DHT blocking effect" is a reasonable lay simplification of its 5-alpha reductase inhibitory activity. The tretinoin-minoxidil claim is accurate and underused in public hair loss content. These are genuine wins.
The problems start with stem cells. Saying stem cells "will increase regeneration of the hair follicles" as a flat statement is not supported by current clinical evidence. Human trials are preliminary at best. The FDA has not approved any stem cell product for androgenetic alopecia. Presenting this in the same breath as finasteride misleads viewers about where this treatment actually sits on the evidence spectrum.
The red light therapy claim that it "wakes up the mitochondria" is technically grounded in low-level laser therapy research on cytochrome c oxidase, but the clinical significance for scalp hair in humans is still debated. Jimenez et al. (2014, American Journal of Clinical Dermatology) showed modest hair count improvements with LLLT devices, but effect sizes are modest. Saying it gives follicles "a big energy boost" oversells it.
The omega oils claim is the weakest mechanistic argument in the video. There is some evidence that omega-3 and omega-6 supplementation may reduce hair shedding, as seen in Leray et al. (2011, Journal of Cosmetic Dermatology), but calling it a meaningful treatment alongside finasteride misrepresents relative efficacy.
What should you actually know?
If you have androgenetic alopecia and want to actually stop losing hair, the evidence hierarchy matters. Finasteride and minoxidil are the two treatments with the deepest clinical track records. Everything else in this video sits further down the evidence ladder, some usefully so, some not.
Adding tretinoin to minoxidil is a legitimate strategy worth discussing with a prescriber. Microneedling as an adjunct to minoxidil has promising small-trial support from Dhurat et al. (2013, Journal of Cutaneous and Aesthetic Surgery). PRP may help, but results vary significantly by preparation protocol and the number of sessions. Ketoconazole shampoo is a low-risk add-on. Red light therapy devices are FDA-cleared for safety, not efficacy, and the evidence is modest. Stem cells for hair loss should be approached with serious skepticism until larger controlled trials exist.
None of these treatments work identically for everyone. Female pattern hair loss, telogen effluvium, and alopecia areata each have different treatment profiles than androgenetic alopecia in men. A video treating all hair loss as one condition is a real limitation here.